journal article·2023-09Open access

Oral Delivery of Protein Drugs via Lysine Polymer‐Based Nanoparticle Platforms

Shuyan Han, Peikun Xin, Qilun Guo, Zhong Cao, Hai Huang, Jun Wu

Advanced Healthcare Materials· Volume 12· Issue 23

Abstract

Abstract Oral delivery of proteins has opened a new perspective for the treatment of different diseases. However, advances of oral protein formulation are usually hindered by protein susceptibility and suboptimal absorption in the gastrointestinal tract (GIT). Polymeric nano drug delivery systems are considered revolutionary candidates to solve these issues, which can be preferably tunable against specific delivery challenges. Herein, a tailored family of lysine‐based poly(ester amide)s (Lys‐aaPEAs) is designed as a general oral protein delivery platform for efficient protein loading and protection from degradation. Insulin, as a model protein, can achieve effective internalization by epithelial cells and efficient transport across the intestinal epithelium layer into the systemic circulation, followed by controlled release in physiological environments. After the oral administration of insulin carried by Lys‐aaPEAs with ornamental hyaluronic acid (HA), mice with type 1 diabetes mellitus showed an acceptable hypoglycemic effect with alleviated complications. A successful oral insulin delivery is associated with patient comfort and convenience and simultaneously avoids the risk of hypoglycemia compared with injections, which is of great feasibility for daily diabetes therapy. More importantly, this versatile Lys‐aaPEAs polymeric library can be recognized as a universal vehicle for oral biomacromolecule delivery, providing more possibilities for treating various diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Pancreatic function and diabetes · Diabetes Management and Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Engineering State Key Laboratory of Oncology in South China Sun Yat‐sen University 518107 Shenzhen P. R. China

Department of Orthopedics the Seventh Affiliated Hospital of Sun Yet‐sen University 5181107 Shenzhen P. R. China

Department of Urology Sun Yat‐sen Memorial Hospital Sun Yat‐sen University 510120 Guangzhou P. R. China

Bioscience and Biomedical Engineering Thrust The Hong Kong University of Science and Technology (Guangzhou) Nansha Guangzhou Guangdong 511400 China

Division of Life Science The Hong Kong Univeristy of Science and Technology Hongkong SAR, China

Funding

National Natural Science Foundation of China

References (53)

Show source-provided references
1. 10.1039/D1CS00686J10.1039/D1CS00686J ↗
2. 10.1039/D0BM01151G10.1039/D0BM01151G ↗
3. 10.1002/anie.20150918310.1002/anie.201509183 ↗
4. 10.1002/adma.20190193510.1002/adma.201901935 ↗
5. 10.1038/nchem.262910.1038/nchem.2629 ↗
6. 10.1002/adma.20210493210.1002/adma.202104932 ↗
7. 10.1038/s41551-019-0465-510.1038/s41551-019-0465-5 ↗
8. 10.1016/j.carbpol.2021.11787310.1016/j.carbpol.2021.117873 ↗
9. 10.1002/adhm.20180028510.1002/adhm.201800285 ↗
10. 10.1016/j.cej.2021.13210710.1016/j.cej.2021.132107 ↗
11. 10.1002/adma.20210204410.1002/adma.202102044 ↗
12. 10.1039/D0SC05328G10.1039/D0SC05328G ↗
13. 10.1021/acsami.1c0058010.1021/acsami.1c00580 ↗
14. 10.1016/j.cclet.2021.08.02010.1016/j.cclet.2021.08.020 ↗
15. 10.1016/j.cclet.2021.10.02310.1016/j.cclet.2021.10.023 ↗
16. 10.1126/sciadv.abm467710.1126/sciadv.abm4677 ↗
17. 10.1016/j.bioactmat.2021.08.00710.1016/j.bioactmat.2021.08.007 ↗
18. 10.1016/j.actbio.2021.08.04610.1016/j.actbio.2021.08.046 ↗
19. 10.1002/anie.20200887910.1002/anie.202008879 ↗
20. 10.1016/j.jcis.2020.12.05410.1016/j.jcis.2020.12.054 ↗
21. 10.1016/j.carbpol.2020.11750410.1016/j.carbpol.2020.117504 ↗
22. 10.1002/advs.20210413410.1002/advs.202104134 ↗
23. 10.1021/acsami.0c1513310.1021/acsami.0c15133 ↗
24. 10.1021/acs.biomac.2c0015010.1021/acs.biomac.2c00150 ↗
25. 10.1016/j.actbio.2018.05.04010.1016/j.actbio.2018.05.040 ↗
26. 10.1021/acsnano.2c0433010.1021/acsnano.2c04330 ↗
27. 10.1016/j.eurpolymj.2020.11024810.1016/j.eurpolymj.2020.110248 ↗
28. 10.1021/acs.molpharmaceut.1c0047410.1021/acs.molpharmaceut.1c00474 ↗
29. 10.1016/S2213-8587(21)00182-010.1016/S2213-8587(21)00182-0 ↗
30. 10.1002/advs.20210561910.1002/advs.202105619 ↗
31. 10.1021/acs.chemrev.0c0106210.1021/acs.chemrev.0c01062 ↗
32. 10.1016/j.matt.2021.08.01110.1016/j.matt.2021.08.011 ↗
33. 10.1021/acs.chemmater.9b0085010.1021/acs.chemmater.9b00850 ↗
34. 10.1016/j.jcis.2018.12.09110.1016/j.jcis.2018.12.091 ↗
35. 10.1021/acsami.7b1892710.1021/acsami.7b18927 ↗
36. 10.1038/s41551-021-00791-010.1038/s41551-021-00791-0 ↗
37. 10.1016/j.cclet.2020.02.03510.1016/j.cclet.2020.02.035 ↗
38. 10.1007/s12274-018-2264-910.1007/s12274-018-2264-9 ↗
39. 10.1016/j.carbpol.2019.11500110.1016/j.carbpol.2019.115001 ↗
40. 10.1039/C7NR08047F10.1039/C7NR08047F ↗
41. 10.1002/adfm.20150500010.1002/adfm.201505000 ↗
42. 10.1016/j.bioactmat.2017.07.00410.1016/j.bioactmat.2017.07.004 ↗
43. 10.1021/acsami.5b0742710.1021/acsami.5b07427 ↗
44. 10.1021/acsami.6b0818310.1021/acsami.6b08183 ↗
45. 10.1039/D0BM01772H10.1039/D0BM01772H ↗
46. 10.1002/adtp.20210014510.1002/adtp.202100145 ↗
47. 10.1021/acsnano.8b0723110.1021/acsnano.8b07231 ↗
48. 10.1002/smll.20180046210.1002/smll.201800462 ↗
49. 10.1126/sciadv.aaz177410.1126/sciadv.aaz1774 ↗
50. 10.1007/s11426-020-9802-010.1007/s11426-020-9802-0 ↗
51. 10.1038/s41565-021-00858-810.1038/s41565-021-00858-8 ↗
52. 10.1016/j.addr.2021.05.00510.1016/j.addr.2021.05.005 ↗
53. 10.1016/S0140-6736(13)60591-710.1016/S0140-6736(13)60591-7 ↗